4//SEC Filing
WYNNEFIELD PARTNERS SMALL CAP VALUE LP 4
Accession 0001104659-24-106795
CIK 0001005286other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 8:45 PM ET
Size
23.1 KB
Accession
0001104659-24-106795
Insider Transaction Report
Form 4
WYNNEFIELD CAPITAL INC
10% Owner
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes) - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes) - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total
WYNNEFIELD CAPITAL MANAGEMENT LLC
10% Owner
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes)
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes) - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes)
LANDES JOSHUA
10% Owner
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes) - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes)
OBUS NELSON
10% Owner
Transactions
- Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+169,753$695,987→ 2,607,433 total(indirect: See Footnotes) - Purchase
Common Stock, $0.001 par value per share
2024-10-03$4.10/sh+122,930$504,013→ 2,095,783 total
Footnotes (6)
- [F1]The Reporting Person directly beneficially owns 2,095,783 shares of common stock, $0.001 par value per share ("Common Stock") of Lifecore Biomedical, Inc. Wynnefield Capital Management, LLC, as the sole general partner of the Reporting Person, has an indirect beneficial ownership interest in the shares of Common Stock that the Reporting Person directly beneficially owns. Nelson Obus and Joshua Landes, as co-managing members of Wynnefield Capital Management, LLC, have an indirect beneficial ownership interest in the shares of Common Stock that the Reporting Person directly beneficially owns. Does not include 243,814 shares of Common Stock issuable upon conversion of certain shares of Series A Convertible Preferred Stock, par value $0.001 per share (the "Convertible Preferred Stock") that are immediately convertible.
- [F2]The Reporting Person has an indirect beneficial ownership interest in 1,344,585 shares of Common Stock, which are directly beneficially owned by Wynnefield Partners Small Cap Value, L.P., as members of a group under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Wynnefield Partners Small Cap Value, L.P., which maintains offices at the same address as the Reporting Person, is filing this statement jointly with the Reporting Person. Wynnefield Capital Management, LLC, as the sole general partner of Wynnefield Partners Small Cap Value, L.P., has an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Partners Small Cap Value L.P. directly beneficially owns.
- [F3]Nelson Obus and Joshua Landes, as co-managing members of Wynnefield Capital Management, LLC, have an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Partners Small Cap Value, L.P. directly beneficially owns. Does not include 162,543 shares of Common Stock issuable upon conversion of certain shares of Convertible Preferred Stock that are immediately convertible.
- [F4]The Reporting Person has an indirect beneficial ownership interest in 895,498 shares of Common Stock, which are directly beneficially owned by Wynnefield Small Cap Value Offshore Fund, Ltd., as members of a group under Section 13(d) of the Exchange Act. Wynnefield Small Cap Value Offshore Fund, Ltd., which maintains offices at the same address as the Reporting Person, is filing this statement jointly with the Reporting Person. Wynnefield Capital, Inc. as the sole investment manager of Wynnefield Small Cap Value Offshore Fund, Ltd., has an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Small Cap Value Offshore Fund, Ltd. directly beneficially owns.
- [F5]Nelson Obus and Joshua Landes, as principal executive officers of Wynnefield Capital, Inc., have an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Small Cap Value Offshore Fund, Ltd. directly beneficially owns. Does not include 101,589 shares of Common Stock issuable upon conversion of certain shares of Convertible Preferred Stock that are immediately convertible.
- [F6]The Reporting Person has an indirect beneficial ownership interest in 367,350 shares of Common Stock, which are directly beneficially owned by Wynnefield Capital, Inc. Profit Sharing Plan, as members of a group under Section 13(d) of the Exchange Act. Wynnefield Capital, Inc. Profit Sharing Plan, which maintains offices at the same address as the Reporting Person, is filing this Form jointly with the Reporting Person. Mr. Obus and Mr. Landes, as co-trustees, has the power to vote and dispose of Wynnefield Capital, Inc. Profit Sharing Plan's investments in securities and has an indirect beneficial ownership interest in the shares of Common Stock that Wynnefield Capital, Inc. Profit Sharing Plan directly beneficially owns.
Documents
Issuer
LIFECORE BIOMEDICAL, INC. \DE\
CIK 0001005286
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0000899083
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 8:45 PM ET
- Size
- 23.1 KB